CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 36 filers reported holding CYCLERION THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,105,683 | -33.9% | 7,157,601 | 0.0% | 0.15% | -42.3% |
Q4 2022 | $4,696,818 | -23.7% | 7,157,601 | 0.0% | 0.25% | -36.8% |
Q3 2022 | $6,156,000 | +56.7% | 7,157,601 | 0.0% | 0.40% | +63.3% |
Q2 2022 | $3,928,000 | -50.6% | 7,157,601 | 0.0% | 0.24% | -39.8% |
Q1 2022 | $7,945,000 | -35.5% | 7,157,601 | 0.0% | 0.41% | -36.9% |
Q4 2021 | $12,311,000 | -44.0% | 7,157,601 | 0.0% | 0.64% | -35.7% |
Q3 2021 | $21,974,000 | -21.3% | 7,157,601 | 0.0% | 1.00% | -35.7% |
Q2 2021 | $27,915,000 | +61.5% | 7,157,601 | +15.5% | 1.56% | +39.1% |
Q1 2021 | $17,287,000 | -8.8% | 6,196,063 | 0.0% | 1.12% | +9.3% |
Q4 2020 | $18,960,000 | -49.7% | 6,196,063 | 0.0% | 1.03% | -52.1% |
Q3 2020 | $37,672,000 | +432.9% | 6,196,063 | +418.0% | 2.14% | +414.1% |
Q2 2020 | $7,069,000 | +123.0% | 1,196,063 | 0.0% | 0.42% | +71.6% |
Q1 2020 | $3,170,000 | -70.3% | 1,196,063 | +35.9% | 0.24% | -65.6% |
Q3 2019 | $10,666,000 | +30.5% | 880,000 | +23.2% | 0.71% | +92.4% |
Q2 2019 | $8,176,000 | – | 714,018 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Slate Path Capital LP | 7,157,601 | $3,105,683 | 0.15% |
Artal Group S.A. | 2,779,122 | $1,206 | 0.07% |
MFN Partners Management, LP | 3,389,215 | $1,470,580 | 0.07% |
Intrinsic Value Partners, LLC | 43,105 | $18,703 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $49,899 | 0.00% |
Penobscot Investment Management Company, Inc. | 10,000 | $4,339 | 0.00% |
COLONY GROUP LLC | 102,884 | $44 | 0.00% |
CAPTRUST FINANCIAL ADVISORS | 292,645 | $126,979 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 592,237 | $256,971 | 0.00% |
STATE STREET CORP | 115,414 | $50,078 | 0.00% |